Gianluigi Savarese
Gianluigi Savarese is an expert in Cardiology at Karolinska Institute (Sweden). As of October 2026, ScienceLeadR ranks Gianluigi Savarese in the top 1% of experts worldwide for Heart Failure, and in the top 1% of experts in Sweden for Iron Deficiencies and Iron Metabolism Disorders. Gianluigi Savarese has authored 563 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 2,498 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Endocrinology - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Gianluigi Savarese is an Italian/Swedish cardiologist, currently Professor of Cardiology at Karolinska Institutet (Department of Clinical Science and Education) where he is head of the Center for Heart Failure and Arrhythmia. He is also Senior Consultant for Heart Failure at the Southern Hospital, Stockholm, Sweden. Over the last few years, he has published >400 articles on top peer reviewed journals. Major focus of his research is heart failure, with a particular interest in implementing use of guidelines recommended treatments, and phenotyping heart failure for improving clinical trial design. He is heavily involved in registry studies (Swedish Heart Failure Registry, ESC registries) and clinical trials, and he is expert in big data analysis. He is Secretary of the Heart Failure Association and he has served as board member and secretary of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Among others, he is Deputy Editor of European Journal of Heart Failure, EHJ-Open, and Associate Editor of JACC: Heart Failure.
Organizations
Career arc: 2012 - 2026
Number : 563
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy 2025-522553-19-00 — exercise, cardiomyopathy, dilated, safety, cardiomyopathies | Phase 2/Phase 3 | Recruiting | 2026 |
| Registry BAsed Optimization Of Therapy in Heart Failure NCT07154758 — registries, heart failure, pharmaceutical preparations, heart, mass screening, ambulatory care facilities, heart failure, systolic, therapeutics, outpatients | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map